|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A BRIEF STUDY BETWEEN INNOVATOR DRUGS AND BRANDED DRUGS: A REVIEW |
| Authors Name: | Dr.D.Nagarjuna Reddy , Dr. K.Nageswara Rao , Dr.D.Raghava , Dr.V. Rama Rao |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_184286
|
| Published Paper Id: | IJNRD2211246 |
| Published In: | Volume 7 Issue 11, November-2022 |
| DOI: | |
| Abstract: | While a new drug is located, the company that discovered it would practice for patency to save you different companies from generating and promoting the drug. This patency may additionally soak up to twenty years and for the duration of this period, the company will produce and sell the drug below a logo call to get better its funding and make some earnings. But after the patency expires, other companies are allowed to produce a similar drug. It is what gave rise to brand and generic name in drugs. This articles gives a brief explanation on innovator and Generic drugs and steps involved during Generic drug development process. |
| Keywords: | Innovator drugs, Generic drugs, Branded drugs, BMR |
| Cite Article: | "A BRIEF STUDY BETWEEN INNOVATOR DRUGS AND BRANDED DRUGS: A REVIEW", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.c359-c364, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211246.pdf |
| Downloads: | 000118752 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2211246 Registration ID: 184286 Published In: Volume 7 Issue 11, November-2022 DOI (Digital Object Identifier): Page No: c359-c364 Country: Bhimavaram, Andhra Pradesh, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2211246 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2211246 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn